Sep 24, 2024 at 6:23 AM#11
HPLC_Greg — wow. This community is amazing.
21 18newstart_MO, mia_MS2, LeilaHI and 18 others
Reply Quote Save Share Report
Sep 24, 2024 at 6:40 AM#12
Slightly tangential to Brazil ANVISA GLP-1 but Dr.EM_Chicago reminded me — what is the latest on the oral formulations?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.
39 24wei_SG, cory_ATX, lori_vegas and 36 others
Reply Quote Save Share Report
Sep 24, 2024 at 6:57 AM#13
Thanks for sharing this, Dr.EM_Chicago. A few questions about your Brazil ANVISA GLP-1 experience:
- What dose are you currently on?
- How long before you noticed significant changes?
- Did your doctor have any specific recommendations about Brazil ANVISA?
I am in a similar boat and trying to learn from others' experiences before my next appointment.
45 11NurseAsh_DET, BenResearch_OR, MikeKY_noInsulin and 42 others
Reply Quote Save Share Report
Sep 24, 2024 at 7:14 AM#14
OP here — wow, did not expect this much response! Thank you all for the thoughtful replies on Brazil ANVISA GLP-1.
To answer Dr.LipidDallas: yes, I am on compounded sema from a 503B pharmacy.
Quick update: things are still going well. Thanks again for the evidence-based discussion — this is exactly why I posted in a science-based community. 🙏
10 15lucas_SP_BR, lisa_labSD, adam_van and 7 others
Reply Quote Save Share Report
Sep 24, 2024 at 7:31 AM#15
Relevant to Brazil ANVISA GLP-1 approvals — here is my latest bloodwork comparison:
Key improvements: A1C 7.6% → 5.5%, triglycerides 213 → 113 mg/dL, hsCRP 8.0 → 1.3 mg/L. All on tirzepatide for 17 months.
The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.
Last edited: Sep 24, 2024 at 8:31 AM
4 24mike_nyc, VendorMark, COA_Karl and 1 other
Reply Quote Save Share Report